NCT01545037

Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome

Effect of Lactobacillus Acidophilus CL1285®, L. Casei LBC80R® and L. Rhamnosus CLR2® on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 117 (actual)
• Sponsor: Bio-K Plus International Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of Bio-K+ on symptoms of IBS.

Detailed description

Given the promising clinical results of previous trials of probiotics for IBS symptoms, the objective of this clinical trial is to evaluate the safety and effectiveness of a proprietary probiotic product, Lactobacillus acidophilus CL1285®, Lactobacillus casei LBC80R® and Lactobacillus rhamnosus CLR2® on symptoms of IBS in otherwise healthy adults.

Conditions

• Irritable Bowel Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	L. acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2®	Each capsule contains 50 billion cfu live of Lactobacillus acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2® bacterias. The randomized subjects will consume 2 capsules per day at breakfast.
OTHER	Placebo	The placebo capsules are identical in shape, taste, and smell yet are devoid of live bacteria.

Timeline

• Start date: 2012-07-01
• Primary completion: 2015-01-01
• Completion: 2015-01-01
• First posted: 2012-03-06
• Last updated: 2017-07-31

Locations

3 sites across 1 country: United States